SIGN UP
LOG IN
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga·04/28/2025 21:05:47
Listen to the news
Gainers
- Tevogen Bio Holdings (NASDAQ:TVGN) stock moved upwards by 40.8% to $1.32 during Monday's after-market session. The market value of their outstanding shares is at $231.0 million.
- CytomX Therapeutics (NASDAQ:CTMX) stock increased by 8.77% to $0.77. The market value of their outstanding shares is at $61.6 million.
- Autonomix Medical (NASDAQ:AMIX) stock rose 8.29% to $2.48. The market value of their outstanding shares is at $6.1 million.
- Onconetix (NASDAQ:ONCO) stock rose 7.9% to $0.09. The company's market cap stands at $1.3 million.
- Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares moved upwards by 6.55% to $0.3. The market value of their outstanding shares is at $4.2 million.
- Genfit (NASDAQ:GNFT) stock increased by 6.16% to $3.79. The market value of their outstanding shares is at $188.9 million. The company's, FY earnings came out 2 days ago.
Losers
- Anavex Life Sciences (NASDAQ:AVXL) shares declined by 12.6% to $8.37 during Monday's after-market session. The company's market cap stands at $712.2 million.
- Y-mAbs Therapeutics (NASDAQ:YMAB) shares decreased by 10.38% to $3.8. The market value of their outstanding shares is at $170.1 million.
- Forian (NASDAQ:FORA) shares fell 8.97% to $1.93. The market value of their outstanding shares is at $60.2 million.
- Relmada Therapeutics (NASDAQ:RLMD) shares decreased by 8.53% to $0.33. The company's market cap stands at $10.7 million.
- DBV Technologies (NASDAQ:DBVT) shares fell 7.31% to $8.5. The market value of their outstanding shares is at $232.3 million.
- Lipella Pharmaceuticals (NASDAQ:LIPO) stock declined by 6.95% to $2.41. The company's market cap stands at $6.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.